Resources
Resources
Access to mentors with deep expertise in specific areas critical to your growth.
Our XIRs are exceptional individuals who are recognized leaders in their fields, vetted by our team. They’re available for office hours and one-on-one mentoring sessions.
Yvonne Li
XIR, Finance
Yvonne Li
XIR, Finance
Yvonne Li has 20+ years of biotech experience in finance, accounting, strategic planning, and administration.
She has held senior roles including interim CFO, Principal Financial and Accounting Officer, Chief Administrative Officer, SVP of Finance and VP of Finance at Senti Bio, Nkarta Therapeutics, Amunix and OncoMed Pharmaceuticals.
A CPA (inactive) and member of the AICPA, she has hands-on experience growing startups from 15 employees to IPO, managing collaborations, and closing a cross-border merger.
Yvonne is a dynamic leader who builds high-performing teams and fosters a culture of trust and accountability.
She holds a BA from National Taiwan Normal University and an MBA from San Francisco State University.
Denis Bronnikov, PhD
XIR, Business Development
Denis Bronnikov
XIR, Business Development
Denis is a business development executive passionate about bringing innovative healthcare solutions to patients. Experienced in representing key stakeholders in the drug discovery, development and commercialization journey, he has supported portfolio growth at Big Pharma companies and privately owned ventures spanning multiple geographies, including North America, Europe, Emerging Markets and variety of products in therapeutics, diagnostics, and digital health.
Denis describes his approach as bringing a blend of scientific acumen with business insights, mixed with creativity and curiosity. Armed with dual credentials in science and business and having worked across various cultures, he has a deep appreciation for diversity.
His practical and focused approach to value creation has enabled him to execute dozens of mutually beneficial strategic partnerships, from traditional risk-sharing agreements to acquisitions and divestitures.
Lynne Krummen, PhD
XIR, Regulatory
Lynne Krummen
XIR, Regulatory
Lynne holds a Ph.D. in Endocrinology from the University of Cincinnati College of Medicine and has worked in the Biotechnology industry for 35 years.
Her roles have included Global Head of Regulatory CMC and Head of Technical Development at Genentech/Roche as well as Head of Regulatory and Product Development at Vir Biotechnology.
Her development experience spans multiple molecular modalities including biologics, ADCs, small molecules, siRNA, gene therapy and combination products developed for a broad spectrum of clinical settings including oncology, immunology and infectious diseases.
Todd Renshaw
XIR, CMC Operations
Todd Renshaw
XIR, CMC Operations
Todd Renshaw is the founder and managing director of Downeast Biopharma Consulting LLC and serves as Expert-in-Residence in biopharmaceutical outsourcing and operations at UC Berkeley’s Bakar Bio Labs. He previously led manufacturing and supply chain operations at Vir Biotechnology, where he built global networks for developing and manufacturing multiple therapeutic modalities and helped secure over $1 billion in government funding for pandemic preparedness. Prior to this, he led global clinical and commercial outsourced process development and manufacturing for Genentech/Roche. Earlier in his career, he worked in operations and supply chain consulting at PRTM (now PwC) and process development at Merck. Renshaw holds a degree in Chemical Engineering from MIT and an MBA from Harvard Business School.
Bakar Bio Labs tenants have inside access to QWEST, a fully-funded workforce development program.
In the competitive QB3 Workforce Education for Science and Technology (QWEST) program, undergraduate UC Berkeley students are selected for training and work experience over the summer months at participating Bakar Bio Labs tenants. Many students choose to continue work-study through the fall and into the spring. The internship, which can last for six months, is fully paid by QB3. The goal is to generate high-value employees who will be assets to fast-growing companies in the Bay Area and wider California life science sector.
There’s also the opportunity to select motivated, skilled students from QB3-Berkeley’s separate undergrad internship program.
Our communications team promotes our tenants’ successes through newsletters and social media. We help get the word out about job openings. Got an interesting story? We’ll do media outreach for you. If you’ve got an interview coming up, we can help you prep.
Collin Blinder
Deputy Director of Communications, QB3 and Bakar Labs
Collin Blinder
Deputy Director of Communications, QB3 and Bakar Labs
Collin Blinder is the Deputy Director of Communications at Bakar Labs and QB3. He helps spread the word about the amazing work our tenants, members, and partners are doing. From the smallest startup milestone to the largest conference, every development at Bakar Labs and QB3 presents an exciting story to tell. Collin previously worked as a science journalist and communicator, and received his M.S. in Science Communications from UC Santa Cruz.
Kaspar Mossman, PhD
Managing Director, QB3; Communications, Bakar Labs
Kaspar Mossman
Managing Director, QB3; Communications, Bakar Labs
Kaspar Mossman, managing director at QB3, plays a central role in QB3 strategy and manages its early-stage entrepreneurship support including the mentorship program, SBIR workshop, IP landscape program, and legal support. Together with QB3’s grants coordinator, he leads QB3’s collaborative research program. He also heads marketing & communications at QB3 and Bakar Labs. Previously, he worked on the media staff at Proceedings of the National Academy of Sciences and held an AAAS mass media fellowship at Scientific American. He earned a PhD in biophysics from UC Berkeley.
